Phytochemical characterization of an adaptogenic preparation from Rhodiola heterodonta.
Journal: 2010/January - Natural Product Communications
ISSN: 1934-578X
PUBMED: 19768982
Abstract:
The phytochemical constituents of a biologically active, standardized, 80% ethanol extract of Rhodiola heterodonta were characterized. The extract was fractionated over a Sephadex LH-20 column to afford two main fractions representing two classes of secondary metabolites: phenylethanoids and proanthocyanidins. This fractionation facilitated the identification and quantification of individual compounds in the fractions and sub-fractions using HPLC, and LC-MS. The major compounds in the phenylethanoid fraction were heterodontoside, tyrosol methyl ether, salidroside, viridoside, mongrhoside, tyrosol, and the cyanogenic glucoside rhodiocyanoside A. These seven compounds comprised 17.4% of the EtOH extract. Proanthocyanidins ranged from oligomers to polymers based on epigallocatechin and gallate units. The main identified oligomeric compounds in the proanthocyanidin fraction were epigallocatechin gallate, epigallocatechin-epigallocatechin-3-O-gallate and 3-O-galloyl-epigallocatechin-epigallocatechin-3-O-gallate, which constituted 1.75% of the ethanol extract. Tyrosol methyl ether, mongrhoside, and the two proanthocyanidin dimers were reported for the first time from this species in this study. Intraperitoneal injection of the 80% ethanol extract increased survival time of mice under hypoxia by 192%, as an indication of adaptogenic activity.
Relations:
Content
Citations
(3)
References
(16)
Grants
(1)
Conditions
(1)
Drugs
(2)
Chemicals
(5)
Organisms
(3)
Similar articles
Articles by the same authors
Discussion board
Nat Prod Commun 4(8): 1053-1058

Phytochemical Characterization of an Adaptogenic Preparation from <em>Rhodiola heterodonta</em>

Experimental

General

Commercial standards of tyrosol, salidroside, and epigallocatechin-3-O-gallate were purchased from Chromadex (Laguna Hills, CA). Tyrosol methyl ether, viridoside, mongrhoside, heterodontoside, rhodiocyanoside A, epigallocatechin-epigallocatechin-3-O-gallate, and 3-O-galloyl-epigallocatechin-epigallocatechin-3-O-gallate were isolated from R. heterodonta in our laboratory. Lipophilic Sephadex LH-20 (Sigma, St. Louis, MO) and silica gel 60, 230–400 mesh ASTM (Merck, Whitehouse Station, NJ) were used for column chromatography.

Instruments and chromatographic conditions

The NMR spectra were obtained on a Varian Inova spectrometer (Palo Alto, CA), using TMS as internal standard.

HPLC-ESI-MS analyses

These were made with an LCQ Deca XP mass spectrometer (Thermo Finnegan Corp., San Jose, CA), MS version 1.3 SRI, ESI in the positive ion mode (m/z 200-2000), with a photodiode array (PDA) detector (200-600 nm), version 1.2, auto-sampler version 1.2, and Xcalibur software for data processing. The HPLC separations were carried out on a C18 reversed-phase column (150 mm, 2.1 mm i.d., particle size 5 μm, 90 Å) (VYDAC, Western Analytical, Murrieta, CA). The mobile phase consisted of 95% H2O, 5% acetonitrile and 0.1% formic acid (solvent A), and 95% acetonitrile, 5% H2O, and 0.1% formic acid (solvent B) with a step gradient of 0%, 5%, 30%, 60%, 90%, 90%, 0% and 0% of solvent B at 0, 3, 40, 45, 50, 55, 60 and 70 min, respectively. A constant flow rate of 200 μL/min and an injection volume of 10 μL were employed. Standards or samples (2, 5 mg/mL) were prepared in MeOH, filtered and injected.

HPLC-PDA analyses

These were performed using an Agilent 1100 HPLC system (Agilent Technologies Inc., New Castle, DE).

For phenylethanoid quantification, a 150 mm × 4.6 mm × 5 μm Eclipse XDB C18 reversed-phase column (Agilent Technologies Inc.) was used. The elution gradient consisted of three solvents: (A) 100% H2O with 25 mM phosphate buffer and pH 7.0, (B) 100% acetonitrile, and (C) MeOH 100% with 0.1% phosphoric acid [27]. Gradient elution started with 95:5 (A:B), proceeded to 80:20 (A:B) in 30 min, and sustained at this ratio until 37 min. Solvent C was used to flush the column for 5 min, then the elution continued with 95:5 (A:B) for another 5 min to equilibrate the column before injecting the next sample. The column temperature was set at 50°C with a constant flow rate of 0.8 mL/min. The photodiode array detector was set to record absorption at 225 nm.

For proanthocyanidins quantification, a reversed-phase Supelcosel LC18 column 250 mm × 4 mm × 5 μm (Supelco, Bellefonte, PA) was used. Solvent systems and elution gradient were as described above (in HPLC-ESI-MS analyses). The column temperature was 250°C with a constant flow rate (1 mL/min) and the UV detection was at 280 nm.

Commercial standards or standards purified in our laboratory were used for this analysis. Three concentrations of each standard were prepared at 0.25, 0.50, and 1.00 mg/mL in MeOH. Fraction A (10 mg/mL) and fraction C (2 mg/mL) were also prepared in MeOH. Samples or standards were filtered (0.22 μm PTFE) and an aliquot (5 μL) was injected.

Plant material

Rhizomes of Rhodiola heterodonta (Hook. f &amp; Thomson) Boriss. (ICBG Central Asia voucher UPL_00085, ILLS, MO) were harvested from mountainous regions of Uzbekistan in 2004. Since the traditional use of this plant in herbal therapy has been in the form of a hydro-alcoholic solution, an 80% aq. ethanol extract was prepared and used for this study.

Extraction, isolation and sample preparation

Fine powdered lyophilized rhizomes (96 g) were extracted with 80% aq. ethanol (3 × 1L) at room temperature. The solvent was evaporated and the residual aqueous extract was lyophilized (36 g). For isolation of standard compounds, 16.0 g of the dry 80% EtOH extract was fractionated over Sephadex LH-20 (5 × 25 cm), first eluting with 1L 100% EtOH to give fraction (A) and then followed by subsequent elution with a mixture of MeOH-Me2CO-H2O (1:1:1, 1L) to obtain fraction (B). Fraction A was further fractionated to yield the following pure compounds: tyrosol methyl ether, tyrosol, viridoside, salidroside, rhodiocyanoside A, mongrhoside, and heterodontoside. The isolated compounds were identified through TLC, HPLC, NMR, ESI-MS and comparison of their spectral data with commercial reference compounds (tyrosol and salidroside), and with previously isolated and identified compounds [15]. Mongrhoside was identified by comparing its chemical and spectral data with the published data [25]. Fraction B was dissolved in H2O and partitioned with EtOAc (fraction C). A total of 75 mg of sub-fraction (C) was separated using a semi-preparative Genesis C18 column, 50 mm × 22.5 mm × 15 μm (VYDAC, Chromtech, Apple Valley, MN) using PDA detector at 280 nm. The injection volume was 100 μL with a flow rate of 2 mL/min. Solvent A was 100% H2O and solvent B was 100% MeOH. The gradient system was 5%, 30%, 60%, 90%, 90%, 5%, and 5% of solvent B at 0, 40, 45, 50, 55, 60, and 70 min, respectively. For each proanthocyanidin peak, a total of 1000 mL was collected from multiple injections and dried under reduced pressure (temperature < 40°C) where about 5 mg, 7 mg, and 10 mg were obtained for the three peaks, respectively. Isolated compounds were identified as epigallocatechin-epigallocatechin-3-O-gallate, 3-O-galloyl-epigallocatechin-epigallocatechin-3-O-gallate, and epigallocatechin gallate. The purities of all isolated compounds were > 95%, as determined by analytical HPLC and NMR analyses.

Quantitative analysis

Three 1.0 g samples of the 80% EtOH dry extract were individually fractionated over Sephadex LH-20 columns (28 × 2 cm), in the same was as above. Fraction A was eluted with ethanol (150 mL, 554.0 ±7.2 mg) while Fraction (B) was obtained by subsequent elution with MeOHMe2CO-H2O (1:1:1, 300 mL) (416.0 ± 17.1 mg). Fraction B was dissolved in H2O (20 mL) and partitioned with EtOAc (3 × 40 mL). Evaporation of the EtOAc layer afforded sub-fraction C (27.7 ± 2.5 mg), while evaporation of the aqueous layer afforded sub-fraction D (365.0 ± 13.2 mg). Fractions A and sub-fraction C were lyophilized and stored at −20°C for HPLC-PDA analyses, to estimate the concentration of phenylethanoids and oligomeric proanthocyanidins in R. heterodonta. HPLC quantification was calculated using a linear regression of the peak area for a known external standard concentration (three levels) with peak area of the corresponding compound in fraction A. The correlation coefficient (R2) between peak area and concentration for the standards was at least 0.98 in the range of 0.25 to 1.00 mg/mL. The concentrations of phenylethanoid and oligomeric proanthocyanidin compounds were expressed as mg/g in the 80% EtOH extract and as % in the fresh and dry rhizome tissue, are presented in Table 2.

Antihypoxic activity

This was determined according to procedures described before [28]. A total of 6 male mice (16-22 g), were intra-peritoneally injected with 40 mg/kg of the 80% ethanol extract dissolved in 0.9% aq. NaCl. The control group (6 male mice of approx. same size) received an equivalent volume of the pure solvent (0.9% NaCl). This treatment was performed 30 min before placing the mice into hermetically closed glass chambers of 550 cm volumes. The treatment did not cause any changes in the general behavior of the mice before they were placed inside the chambers. Time until the last breath was registered for each subject. The investigation was conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996)

General

Commercial standards of tyrosol, salidroside, and epigallocatechin-3-O-gallate were purchased from Chromadex (Laguna Hills, CA). Tyrosol methyl ether, viridoside, mongrhoside, heterodontoside, rhodiocyanoside A, epigallocatechin-epigallocatechin-3-O-gallate, and 3-O-galloyl-epigallocatechin-epigallocatechin-3-O-gallate were isolated from R. heterodonta in our laboratory. Lipophilic Sephadex LH-20 (Sigma, St. Louis, MO) and silica gel 60, 230–400 mesh ASTM (Merck, Whitehouse Station, NJ) were used for column chromatography.

Instruments and chromatographic conditions

The NMR spectra were obtained on a Varian Inova spectrometer (Palo Alto, CA), using TMS as internal standard.

HPLC-ESI-MS analyses

These were made with an LCQ Deca XP mass spectrometer (Thermo Finnegan Corp., San Jose, CA), MS version 1.3 SRI, ESI in the positive ion mode (m/z 200-2000), with a photodiode array (PDA) detector (200-600 nm), version 1.2, auto-sampler version 1.2, and Xcalibur software for data processing. The HPLC separations were carried out on a C18 reversed-phase column (150 mm, 2.1 mm i.d., particle size 5 μm, 90 Å) (VYDAC, Western Analytical, Murrieta, CA). The mobile phase consisted of 95% H2O, 5% acetonitrile and 0.1% formic acid (solvent A), and 95% acetonitrile, 5% H2O, and 0.1% formic acid (solvent B) with a step gradient of 0%, 5%, 30%, 60%, 90%, 90%, 0% and 0% of solvent B at 0, 3, 40, 45, 50, 55, 60 and 70 min, respectively. A constant flow rate of 200 μL/min and an injection volume of 10 μL were employed. Standards or samples (2, 5 mg/mL) were prepared in MeOH, filtered and injected.

HPLC-PDA analyses

These were performed using an Agilent 1100 HPLC system (Agilent Technologies Inc., New Castle, DE).

For phenylethanoid quantification, a 150 mm × 4.6 mm × 5 μm Eclipse XDB C18 reversed-phase column (Agilent Technologies Inc.) was used. The elution gradient consisted of three solvents: (A) 100% H2O with 25 mM phosphate buffer and pH 7.0, (B) 100% acetonitrile, and (C) MeOH 100% with 0.1% phosphoric acid [27]. Gradient elution started with 95:5 (A:B), proceeded to 80:20 (A:B) in 30 min, and sustained at this ratio until 37 min. Solvent C was used to flush the column for 5 min, then the elution continued with 95:5 (A:B) for another 5 min to equilibrate the column before injecting the next sample. The column temperature was set at 50°C with a constant flow rate of 0.8 mL/min. The photodiode array detector was set to record absorption at 225 nm.

For proanthocyanidins quantification, a reversed-phase Supelcosel LC18 column 250 mm × 4 mm × 5 μm (Supelco, Bellefonte, PA) was used. Solvent systems and elution gradient were as described above (in HPLC-ESI-MS analyses). The column temperature was 250°C with a constant flow rate (1 mL/min) and the UV detection was at 280 nm.

Commercial standards or standards purified in our laboratory were used for this analysis. Three concentrations of each standard were prepared at 0.25, 0.50, and 1.00 mg/mL in MeOH. Fraction A (10 mg/mL) and fraction C (2 mg/mL) were also prepared in MeOH. Samples or standards were filtered (0.22 μm PTFE) and an aliquot (5 μL) was injected.

Plant material

Rhizomes of Rhodiola heterodonta (Hook. f &amp; Thomson) Boriss. (ICBG Central Asia voucher UPL_00085, ILLS, MO) were harvested from mountainous regions of Uzbekistan in 2004. Since the traditional use of this plant in herbal therapy has been in the form of a hydro-alcoholic solution, an 80% aq. ethanol extract was prepared and used for this study.

Extraction, isolation and sample preparation

Fine powdered lyophilized rhizomes (96 g) were extracted with 80% aq. ethanol (3 × 1L) at room temperature. The solvent was evaporated and the residual aqueous extract was lyophilized (36 g). For isolation of standard compounds, 16.0 g of the dry 80% EtOH extract was fractionated over Sephadex LH-20 (5 × 25 cm), first eluting with 1L 100% EtOH to give fraction (A) and then followed by subsequent elution with a mixture of MeOH-Me2CO-H2O (1:1:1, 1L) to obtain fraction (B). Fraction A was further fractionated to yield the following pure compounds: tyrosol methyl ether, tyrosol, viridoside, salidroside, rhodiocyanoside A, mongrhoside, and heterodontoside. The isolated compounds were identified through TLC, HPLC, NMR, ESI-MS and comparison of their spectral data with commercial reference compounds (tyrosol and salidroside), and with previously isolated and identified compounds [15]. Mongrhoside was identified by comparing its chemical and spectral data with the published data [25]. Fraction B was dissolved in H2O and partitioned with EtOAc (fraction C). A total of 75 mg of sub-fraction (C) was separated using a semi-preparative Genesis C18 column, 50 mm × 22.5 mm × 15 μm (VYDAC, Chromtech, Apple Valley, MN) using PDA detector at 280 nm. The injection volume was 100 μL with a flow rate of 2 mL/min. Solvent A was 100% H2O and solvent B was 100% MeOH. The gradient system was 5%, 30%, 60%, 90%, 90%, 5%, and 5% of solvent B at 0, 40, 45, 50, 55, 60, and 70 min, respectively. For each proanthocyanidin peak, a total of 1000 mL was collected from multiple injections and dried under reduced pressure (temperature < 40°C) where about 5 mg, 7 mg, and 10 mg were obtained for the three peaks, respectively. Isolated compounds were identified as epigallocatechin-epigallocatechin-3-O-gallate, 3-O-galloyl-epigallocatechin-epigallocatechin-3-O-gallate, and epigallocatechin gallate. The purities of all isolated compounds were > 95%, as determined by analytical HPLC and NMR analyses.

Quantitative analysis

Three 1.0 g samples of the 80% EtOH dry extract were individually fractionated over Sephadex LH-20 columns (28 × 2 cm), in the same was as above. Fraction A was eluted with ethanol (150 mL, 554.0 ±7.2 mg) while Fraction (B) was obtained by subsequent elution with MeOHMe2CO-H2O (1:1:1, 300 mL) (416.0 ± 17.1 mg). Fraction B was dissolved in H2O (20 mL) and partitioned with EtOAc (3 × 40 mL). Evaporation of the EtOAc layer afforded sub-fraction C (27.7 ± 2.5 mg), while evaporation of the aqueous layer afforded sub-fraction D (365.0 ± 13.2 mg). Fractions A and sub-fraction C were lyophilized and stored at −20°C for HPLC-PDA analyses, to estimate the concentration of phenylethanoids and oligomeric proanthocyanidins in R. heterodonta. HPLC quantification was calculated using a linear regression of the peak area for a known external standard concentration (three levels) with peak area of the corresponding compound in fraction A. The correlation coefficient (R2) between peak area and concentration for the standards was at least 0.98 in the range of 0.25 to 1.00 mg/mL. The concentrations of phenylethanoid and oligomeric proanthocyanidin compounds were expressed as mg/g in the 80% EtOH extract and as % in the fresh and dry rhizome tissue, are presented in Table 2.

Antihypoxic activity

This was determined according to procedures described before [28]. A total of 6 male mice (16-22 g), were intra-peritoneally injected with 40 mg/kg of the 80% ethanol extract dissolved in 0.9% aq. NaCl. The control group (6 male mice of approx. same size) received an equivalent volume of the pure solvent (0.9% NaCl). This treatment was performed 30 min before placing the mice into hermetically closed glass chambers of 550 cm volumes. The treatment did not cause any changes in the general behavior of the mice before they were placed inside the chambers. Time until the last breath was registered for each subject. The investigation was conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996)

Acknowledgments

We gratefully acknowledge the support of Fogarty International Center of the NIH under U01 TW006674 for the International Cooperative Biodiversity Groups.

Natural Resources and Environmental Sciences Department, University of Illinois, Urbana, IL 61801, USA
Scientific Research Institute of Cardiology, Ministry of Health of the Republic of Uzbekistan, Tashkent, Uzbekistan
Rutgers University, SEBS, Foran Hall, 59 Dudley Road, New Brunswick, NJ 08901, USA
ude.cuiu@lamegami

Abstract

The phytochemical constituents of a biologically active, standardized, 80% ethanol extract of Rhodiola heterodonta were characterized. The extract was fractionated over a Sephadex LH-20 column to afford two main fractions representing two classes of secondary metabolites: phenylethanoids and proanthocyanidins. This fractionation facilitated the identification and quantification of individual compounds in the fractions and sub-fractions using HPLC, and LC-MS. The major compounds in the phenylethanoid fraction were heterodontoside, tyrosol methyl ether, salidroside, viridoside, mongrhoside, tyrosol, and the cyanogenic glucoside rhodiocyanoside A. These seven compounds comprised 17.4% of the EtOH extract. Proanthocyanidins ranged from oligomers to polymers based on epigallocatechin and gallate units. The main identified oligomeric compounds in the proanthocyanidin fraction were epigallocatechin gallate, epigallocatechin-epigallocatechin-3-O-gallate and 3-O-galloylepigallocatechin-epigallocatechin-3-O-gallate, which constituted 1.75% of the ethanol extract. Tyrosol methyl ether, mongrhoside, and the two proanthocyanidin dimers were reported for the first time from this species in this study. Intraperitoneal injection of the 80% ethanol extract increased survival time of mice under hypoxia by 192%, as an indication of adaptogenic activity.

Keywords: Rhodiola heterodonta, HPLC-ESI/MS, phenylethanoid, proanthocyanidin, adaptogenic activity, anti-hypoxia
Abstract

Rhodiola spp. (Crassulaceae) have been known for centuries as medicinal herbs in Eastern Europe and Asia. R. rosea has been popular as an adaptogenic plant [1-5]. The term adaptogen refers to substances which help the body and brain cells resist physical, chemical, and environmental stresses. Repeated administration of adaptogens leads to a stress-protective effect in a way similar to that produced by repeated physical exercise. Adaptogens have a broad range of therapeutic effects without causing any disturbance to the normal functioning of the organism [6-9]. An important direction in modern pharmacy today is to search for drugs that increase working capacity, stability under stressful conditions, and ability to adapt to rapidly-changing industrial and environmental conditions. The increase in body resistance to external stress conditions, like hypoxia, is considered an indication of adaptogenic activity [10,11]. Previously, a series of in vivo experiments to evaluate the increase in endurance of animals under intense physical loads was established as a means to gauge the ability of ingested substances to act as natural adaptogens [12].

Wild species of Rhodiola have been used in traditional medicine systems [13,14], including R. heterodonta, a species endemic to the mountains of Central Asia. Rhodiola species were recently reported to contain phenylethanoid/ propanoid compounds along with other biologically active constituents [15]. Analytical methods to determine salidroside and tyrosol have been reported [16-20], but methods to determine the presence of other co-occurring constituents are very limited. To standardize a pharmaceutical preparation, it is essential to fully characterize and quantify the constituents of the preparation. In this study we used simple and efficient analytical methods for characterization and quantification of multiple components in a R. heterodonta standardized ethanolic preparation that demonstrated an in-vivo antihypoxic efficacy.

Our results showed that administration of the 80% EtOH extract of R. heterodonta (40 mg/kg) increased the life span of the treated mice under hypoxic conditions by 1.9 times compared with the untreated control (Table 1). This increase in the mice tolerance to hypoxia is evidence of the drug’s adaptogenic activity [10]. Our findings are consistent with the published data on epigalokhin, a polymeric proanthocyanidin isolated from a related species, R. semenovii, which exhibited pronounced antihypoxic effect in both in-vivo and in-vitro experiments [21]. Additionally, the most abundant phenylethanoid glycoside, salidroside, was reported to exert a protective effect on PC12 (neuronal pheochromocytoma cells), where it prevented the morphological changes of these cells under conditions of chemical hypoxia induced by Na2S2O4 [22].

Table 1

Antihypoxic activity of the R. heterodonta 80% EtOH extract, intra-peritoneally administered to mice.

life time (min)% life prolongation
Control group128.00 ± 2.14100%
Treated group153.80 ± 14:10192%
Six male mice (16-22 g) were included in control and test groups.

The injected dose of R. heterodonta extract was 40 mg/kg. Each mouse was placed into a550 cm hermetically closed glass chamber.

R. heterodonta rhizome contains a wide range of secondary metabolites including polymeric proanthocyanidins [15], which interfere with direct HPLC analysis. The presence of proanthocyanidin compounds along with phenylethanoids in the EtOH extract made both qualitative and quantitative analysis of both components difficult, for two reasons: the presence of a polymeric proanthocyanidin spectral hump, and overlapping of the peaks from the two groups because of similarity in UV wavelength absorption. An HPLC-PDA analysis of the 80% EtOH extract acquired at 225 nm and 280 nm displayed a complex hump (Figure 1). This problem was reported before, for the analysis of 5 marker compounds in R. rosea [23]. In this study, we separated these compounds on a Sephadex LH-20 column, to two major groups, phenylethanoids (fraction A) and proanthocyanidins (fraction B). This separation facilitated characterization of individual components. Also, partition of fraction B with EtOAc allowed for the separation of three major oligomeric proanthocyanidins (sub-fraction C) from the more complex polymers (sub-fraction D). This separation allowed accurate quantification of oligomeric proanthocyanidins and overcame the chromatographic hump characteristic for polymeric proanthocyanidin mixtures, which would inevitably affect the quantification of other constituents.

An external file that holds a picture, illustration, etc.
Object name is nihms-154712-f0001.jpg

HPLC chromatogram (from LC-MS) for R. heterodonta 80% EtOH extract measured at 225 nm (A), maximum absorption of phenylethanoids, and at 280 nm (B), maximum absorption of proanthocyanidins.

Phenylethanoids isolated from fraction A included tyrosol (1), viridoside (2), salidroside (3), tyrosol methyl ether (4), heterodontoide (5), and mongrhoside (6), and the cyanogenic glucoside rhodiocyanoside A (7) (Figure 2) [15]. Tyrosol methyl ether and mongrhoside were characterized for the first time in this study. Mongrhoside, the arabinose derivative of viridoside, was recently identified in R. quadrifida and R. rosea [24, 25]. H NMR and C NMR spectra were identical to the data recently reported for monrhoside [25].

An external file that holds a picture, illustration, etc.
Object name is nihms-154712-f0002.jpg

Compounds isolated and quantified in R. heterodonta

HPLC-PDA quantification of fraction A (Figure 3), using the above isolated compounds as external standards, revealed that heterodontoside was the most abundant phenylethanoid in the 80% EtOH dry extract of R. heterodonta (53.2 mg/g), followed by tyrosol methyl ether (41.6 mg/g), salidroside (25.8 mg/g), viridoside (22.6 mg/g), and mongrhoside (18.3 mg/g), with tyrosol and rhodiocyanoside A as minor components (5.2 and 7.1 mg/g respectively). Collectively, the concentration of the seven compounds was 173.8 mg/g (17.4%) in the 80% EtOH extract of R. heterodonta. When completely dried, R. heterodonta fresh rhizomes contained 38.2% ± 0.7% dry matter (n = 3), of which 37.5% ± 2.9% constituted the 80% EtOH extract. The 80% EtOH extract constituted 14.3% ± 1.0% (n = 3) of the rhizome fresh weight. The total phenylethanoid/cyanogenic compounds comprised 6.4% and 2.4% of the dry and fresh rhizomes, respectively (Table 2).

An external file that holds a picture, illustration, etc.
Object name is nihms-154712-f0003.jpg

RP-HPLC chromatogram for phenylethanoids and cyanogenic glycosides in R. heterodonta (fraction A, UV 225 nm).

Table 2

Concentrations of the phenylethanoid and cyanogenic glycosides in R. heterodonta 80% EtOH extract and the corresponding percentages in the rhizome dry and fresh tissues.

PG (mg/g)
in EXT2
% PGMW5Rt6

EXT2DT3FT4(min)

Rhodiocyano-
side A
07.1 ± 0.570.70.30.12595.5

Salidroside25.8 ± 1.72.61.00.43008.5

Tyrosol05.2 ± 0.30.50.20.11389.6

Heterodontoside53.2 ± 2.75.32.00.731420.7

Viridoside22.6 ± 3.42.30.80.344621.2

Mongrhoside18.3 ± 3.21.80.70.344621.7

Tyrosol methyl
ether
41.6 ± 2.94.21.50.615227.2

Total173.8 ± 12.017.46.42.4----
PG; phenylethanoid/cyanogenic glycosides
EXT; 80% EtOH extract
DT; dried plant tissue
FT; fresh plant tissue
MW; molecular weight
Rt; retention time (Figure 3)
mean values ± standard deviations (n = 3). Fresh rhizomes contained 38.2% ± 0.7% dry matter (n = 3) or 14.3 % ± 1.0% dry 80% EtOH extract (n = 3). Dry rhizome tissues contained 37.5% ± 2.9% dry 80% EtOH extract.

Fraction B contained a large number of oligomeric and polymeric proanthocyanidins, as indicated by its LC-ESI-MS profile. HPLC-ESI-MS of sub-fraction C (the EtOAc partition from fraction B) revealed that there were three main components with m/z of 763, 915 and 459 [M+H] in the positive ion mode. The three components were isolated utilizing semi-preparative HPLC and identified as: epigallocatechinepigallocatechin-,3-O-gallate (EGC-EGCG, 9), 3-O-galloyl-epigallocatechin-epigallocatechin-3-O-gallate (EGCG-EGCG, 10), and epigallocatechin gallate (EGCG, 8). EGCG was identified by comparing its physical and spectral data with a standard compound. EGC-EGCG (9) and EGCG-EGCG (10) were identified by comparing their physical and NMR characteristics with published data [26]. Compounds 8, 9 &amp; 10 were used as external standards for the HPLC quantification of oligomeric proanthocyanidins in sub-fraction C (Figure 4). The concentrations of EGC-EGCG, EGCG-EGCG, and EGCG in the 80% EtOH extract were 4.35, 4.68, and 8.51 mg/g, respectively. Collectively, the three measured oligomers composed 17.5 ± 0.82 mg/g (n = 3) or 1.75% of the 80% EtOH extract. The three oligomers represented 0.65% and 0.25% of the dry and fresh rhizomes, respectively (Table 3). Sub-fraction D contained a mixture of several complex polymeric compounds and, therefore, it was not analyzed further. This is the first report to quantify oligomeric proanthocyanidins in Rhodiola plants.

An external file that holds a picture, illustration, etc.
Object name is nihms-154712-f0004.jpg

RP-HPLC chromatogram for oligomeric proanthocyanidins in R. heterodonta (sub-fraction C, UV 280 nm). EGC-EGCG = epigallocatechin-epigallocatechin-3-O-gallate, EGCG-EGCG = 3-O-galloyl-epigallocatechin-epigallocatechin-3-O-gallate, EGCG = epigallocatechin gallate.

Table 3

Concentrations of oligomeric proanthocyanidins in R. heterodonta 80% EtOH extract and the corresponding percentages in the rhizome dry and fresh tissues.

PA (mg/g )
in EXT2
% PAMW5Rt6
EXT2DT3FT4(min)
EGC-EGCG4.35 ± 0.5070.440.160.0676210.0
EGCG-EGCG4.68 ± 0.500.470.170.0791413.7
EGCG8.51 ± 0.590.850.320.1245815.3
Total17.50 ± 0.821.750.650.25----
PA; oligomeric proanthocyanidin
EXT; 80% EtOH extract
DT dry plant tissue
FT fresh plant tissue
MW; molecular weight
Rt retention time (Figure 4)
mean values ± standard deviations (n = 3). EGC-EGCG = epigallocatechin-epigallocatechin-3-O-gallate, EGCGEGCG = 3-O-galloyl-epigallocatechin-epigallocatechin-3-O-gallate, EGCG = epigallocatechin gallate. Fresh rhizomes contained 38.2% ± 0.7% dry tissues (n = 3) or 14.3% ± 1.0% dry 80% EtOH extract (n = 3). Dry rhizome tissues contained 37.5% ± 2.9% dry EtOH 80% extract

Data on the concentration of phenylethanoids in Rhodiola species has rarely been reported outside of publications in Russia, China, and other Central Asian countries. In one study it was reported that the concentrations of salidroside and tyrosol ranged from 1.3-11.1 mg/g and 0.3- 2.2 mg/g, respectively in dry Rhodiola rosea rhizomes collected from various parts of China [22]. In another study, the concentration of salidroside in a selection of dried R. rosea samples ranged from 0.4 to 2.7 mg/g [23]. In our study, the concentrations of salidroside and tyrosol were 1.0 and 0.2 mg/g dry weight, respectively, while the methyl ether of tyrosol showed higher concentration (1.5 mg/g dry weight).

References

  • 1. Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea. A phytomedicinal overview. Herbal Gram. 2002;56:40–52.[PubMed]
  • 2. Kelly GS. Rhodiola rosea: A possible plant adaptogen. Alternative Medicine Review. 2001;6:293–302.[PubMed]
  • 3. Khanum F, Bawa AS, Singh B. Rhodiola rosea: A versatile adaptogen. Comprehensive Reviews in Food Science and Food Safety. 2005;4:55–62.[PubMed]
  • 4. Lazarev NVActual problems of the studies of the action of adaptogens, particularly preparations of Eleuterococcus. Symposium on Ginseng and Eleuterococcus; XX meeting on investigations of Ginseng and other medicinal plants of Far East; Vladivostok: DVFSO; 1962. pp. 7–14. [PubMed]
  • 5. Perfumi M, Mattioli LAdaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytotherapy Research. 2007;21:37–43.[PubMed][Google Scholar]
  • 6. Panossian A, Wikman G, Wagner H. Plant adaptogens. Part 3. Earlier and more recent aspects and concepts on their mode of action. Phytomedicine. 1999;6:287–300.[PubMed]
  • 7. Panossian AAdaptogens: Tonic herbs for fatigue and stress. Alternative and Complementary Therapies. 2003;9:327–331.[PubMed][Google Scholar]
  • 8. Panossian A, Wagner HStimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytotherapy Research. 2005;19:819–838.[PubMed][Google Scholar]
  • 9. Wagner H, Noerr H, Winterhoff HPlant adaptogens. Phytomedicine. 1994;1:63–76.[PubMed][Google Scholar]
  • 10. Singh B, Saxena AK, Chandan BK, Gupta DK, Bhutani KK, Anand KKAdaptogenic activity of a novel, withanolide free aqueous fraction from the roots of Withania somnifera. Phytotherapy Research. 2001;15:311–318.[PubMed][Google Scholar]
  • 11. Grover SK, Divekar HM, Kumar R, Pahwa ML, Bhardwaj SK, Gupta AK, Srivastava KKExperimental evaluation of a composite Indian herbal preparation II (CIHP) as an adaptogen and its mechanism of action. Pharmaceutical Biology (formerly International Journal of Pharmacognosy) 1995;33:148–154.[PubMed]
  • 12. Bakibaev AA, Gorshkova VK, Saratikov ASAntihypoxic properties of organic compounds (A review) Pharmaceutical Chemistry Journal. 1997;31:3–16.[PubMed][Google Scholar]
  • 13. Li H, Chen FPreparative isolation and purification of salidroside from the Chinese medicinal plant Rhodiola sachalinensis by high-speed counter-current chromatography. Journal of Chromatography A. 2001;932:91–95.[PubMed][Google Scholar]
  • 14. Ohsugi M, Fan W, Hase K, Xiong Q, Tezuka Y, Komatsu K, Namba T, Saitoh T, Tazawa K, Kadota SActive-oxygen scavenging activity of traditional nourishing-tonic herbal medicines and active constituents of Rhodiola sacra. Journal of Ethnopharmacology. 1999;67:111–119.[PubMed][Google Scholar]
  • 15. Yousef GG, Grace MH, Cheng DM, Belolipov IV, Raskin I, Lila MAComparative phytochemical characterization of three Rhodiola species. Phytochemistry. 2006;67:2380–2391.[PubMed][Google Scholar]
  • 16. Chen Z, Chen Y, Wang DDetermination of the content of salidroside in different Rhodiola varieties by HPLC. Zhongguo Zhongyao Zazhi. 2006;31:939–941.[PubMed][Google Scholar]
  • 17. Hu H, Yang L, Hu H, Li JDetermination of salidroside in Rhodiola L from different districts. Henan Yixue Yanjiu. 2007;16:203–204.[PubMed][Google Scholar]
  • 18. Mao Y, Li Y, Yao NSimultaneous determination of salidroside and tyrosol in extracts of Rhodiola L. by microwave assisted extraction and high-performance liquid chromatography. Journal of Pharmceutical and Biomedical Analysis. 2007;45:510–515.[PubMed][Google Scholar]
  • 19. Meng J, Wang S, Han F, Li SDetermination of salidroside and p-tyrosol in Rhodiola for injection by SPE-HPLC. Zhongguo Zhongyao Zazhi. 2006;31:119–121.[PubMed][Google Scholar]
  • 20. Zhang J, Chen X, Gao G, Bi KSimultaneous HPLC determination of salidroside and tyrosol in Rhodiola crenulata. Yaowu Fenxi Zazhi. 2006;26:1238–1240.[PubMed][Google Scholar]
  • 21. Kurmukov AG, Aizikov MI, Rakhimov SSPharmacology of the plant polyphenol epigalokhin. Farmakol Toksikol. 1986;49:45–48.[PubMed][Google Scholar]
  • 22. Chen Z, Lu Y, Wang Z, Tao X, Wei DProtective effects of salidroside on hypoxic/reoxygenation injury by sodium hyposulfite in PC12 cells. Pharmaceutical Biology. 2007;45:604–612.[PubMed][Google Scholar]
  • 23. Ganzera M, Yala Y, Khan IAAnalysis of marker compounds of Rhodiola rosea L. (golden root) by reversed phase high performance liquid chromatography. Chemical and Pharmaceutical Bulletin. 2001;49:465–467.[PubMed][Google Scholar]
  • 24. Wiedenfeld H, Dumaa M, Malinowski M, Furmanowa M, Narantuya SPhytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida. Pharmazie. 2007;62:308–311.[PubMed][Google Scholar]
  • 25. Zulfiqar A, Fronczek FR, Khan IAPhenylalkanoids and monoterpene analogues from the roots of Rhodiola rosea. Planta Medica. 2008;74:178–181.[PubMed][Google Scholar]
  • 26. Nonaka GI, Muta M, Myricatin INMyricatin, a galloyl flavanonol sulfate, and prodelphinidin gallates from Myrica rubra. Phytochemistry. 1983;22:237–241.[PubMed][Google Scholar]
  • 27. Linh PT, Kim YH, Hong SP, Jian JJ, Kang JSQuantitative determination of salidroside and tyrosol from the underground part of Rhodiola rosea by high performance liquid chromatography. Archives of Pharmacal Research. 2000;23:349–352.[PubMed][Google Scholar]
  • 28. Kurmukov AG, Aizikov MI, Nazrullaev SS, Aripova SF, Tolstikova OV, Abdilalimov OAntihypoxic activity of the alkaloid dipthocarpaine and its synthetic analogs. Pharmaceutical Chemistry Journal. 1993;27:176–178.[PubMed][Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.